Method and reagent system for isolation, identification and/or analysis of leukocytes from whole blood samples
First Claim
1. A lytic reagent composition for selective chemical treatment of a whole blood sample, said lytic reagent composition comprising saponin and a lytic reagent, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
- wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl; and
wherein the relative concentration of the lytic reagent composition is in an effective amount to effect partitioning of a whole blood sample into a lysed red cell fraction and an essentially intact leukocyte fraction in such a state as to allow differential analysis of at least five sub-populations of such leukocytes.
1 Assignment
0 Petitions
Accused Products
Abstract
A lytic reagent composition and a kit of a lytic reagent system are disclosed for the rapid isolation, identification and/or analysis of at least five subpopulations of leukocytes from a whole blood sample. The composition and system have application to any environment in which the study and/or analysis of the leukocyte fraction of whole blood requires their isolation in their native or near native state. The lytic reagent composition of this invention comprises saponin and a carboxylic acid of the formula RCOOH wherein R is H or a C1-3 aliphatic hydrocarbon radial optionally substituted by one or more carbonyl and/or hydroxy groups. The kit of a lytic reagent system comprises the lytic reagent composition and a quench reagent.
77 Citations
33 Claims
-
1. A lytic reagent composition for selective chemical treatment of a whole blood sample, said lytic reagent composition comprising saponin and a lytic reagent, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
-
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl; and wherein the relative concentration of the lytic reagent composition is in an effective amount to effect partitioning of a whole blood sample into a lysed red cell fraction and an essentially intact leukocyte fraction in such a state as to allow differential analysis of at least five sub-populations of such leukocytes. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A lytic reagent composition for selective chemical treatment of a whole blood sample, said lytic reagent composition comprising saponin and a lytic reagent, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
-
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl; and wherein the relative concentration of the lytic reagent composition is in an effective amount to effect partitioning of a whole blood sample into a lysed red cell fraction and a leukocyte fraction by (i) causing rapid and essentially complete hemolysis of red blood cells in the blood sample and, (ii) inducing changes in leukocytes in said blood sample to enhance the ability of instrumentation to perform differential analysis and identification of at least five (5) sub-populations of leukocytes. - View Dependent Claims (7, 8, 9, 10)
-
-
11. A lytic reagent composition for selective chemical treatment of a whole blood sample, said lytic reagent composition comprising a differentiation effective amount of a lytic reagent and saponin, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
-
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl; and wherein the differentiation effective amount of said lytic reagent composition, when added to a whole blood sample, effecting (i) a decrease in the pH of the sample from its physiological level to a pH in the range of from about 2.6 to about 4.0 while maintaining the osmolality of the fluid at less than about 100 mOs, (ii) rapid and essentially complete hemolysis of the red blood cell fraction in the blood sample, and (iii) changes in the leukocyte cell fraction of the blood sample to enhance the ability of instrumentation to perform differential analysis and identification of at least five (5) sub-populations of leukocytes. - View Dependent Claims (12, 13, 14, 15)
-
-
16. A kit of a lytic reagent system for white blood cell differential analysis comprising:
-
(a) a lytic reagent composition for selective chemical treatment of a whole blood sample, said composition comprising saponin and a lytic reagent, wherein said lytic is a reagent carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl;wherein the relative concentration of the lytic reagent composition is in an effective amount to effect partitioning of a whole blood sample into a lysed red cell fraction and an essentially intact leukocyte fraction in such a state as to allow differential analysis of at least five populations of such leukocytes; and (b) a quench reagent, said quench reagent being present in sufficient concentration to retard the lytic activity of the lytic reagent composition and restore the physiological environment of the leukocytes within the sample. - View Dependent Claims (17, 18, 19, 20, 21)
-
-
22. A kit of a lytic reagent system for selective chemical treatment of a whole blood sample comprising:
- a lytic reagent composition comprising;
(a) a lytic reagent composition comprising saponin and a lytic reagent, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl;wherein the relative concentration of the lytic reagent composition is in an effective amount to effect partitioning of a whole blood sample into a lysed red cell fraction and a leukocyte fraction by (i) causing rapid and essentially complete hemolysis of red blood cells in the blood sample and, (ii) inducing changes in leukocytes in said blood sample to enhance the ability of instrumentation to perform differential analysis and identification of at least five sub-populations of leukocytes, and (b) a quench reagent, said quench reagent being present in sufficient concentration to retard the lytic activity of the lytic reagent composition and restore the physiological environment of the leukocytes within the sample. - View Dependent Claims (23, 24, 25, 26, 27)
- a lytic reagent composition comprising;
-
28. A kit of a lytic reagent system for selective chemical treatment of a whole blood sample comprising:
-
(a) a differentiation effective amount of a lytic reagent and saponin, wherein said lytic reagent is a carboxylic acid of the formula RCOOH or a sulphonic acid of the formula R'"'"'SO3 H;
wherein R is H or a C1-3 aliphatic hydrocarbon radical optionally substituted by one or more carbonyl and/or hydroxy groups, and R'"'"' is OH, a C1-3 aliphatic hydrocarbon radical or aryl; and
wherein the differentiation effective amount of said lytic reagent, when added to a whole blood sample, effecting (i) a decrease in the pH of the sample from its physiological level to a pH in the range of from about 2.6 to about 4.0 while maintaining the osmolality of the fluid at less than about 100 mOs, (ii) rapid and essentially complete hemolysis of the red blood cell fraction in the blood sample, and (iii) changes in the leukocyte cell fraction of the blood sample to enhance the ability of instrumentation to perform differential analysis and identification of at least five sub-populations of leukocytes; and(b) a quench reagent, said quench reagent being present in sufficient concentration to retard the lytic activity of the lytic reagent composition and restore the physiological environment of the leukocytes within the sample. - View Dependent Claims (29, 30, 31, 32, 33)
-
Specification